Cittadine Andrew

Monopar Therapeutics Inc. · Chief Operating Officer

Cittadine Andrew is listed in public filings as officer: Chief Operating Officer. This Cittadine Andrew insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Monopar Therapeutics Inc. (MNPR). Investors use Cittadine Andrew's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Monopar Therapeutics Inc.MNPR	--44.8k shares	Grant / ExerciseMar 31, 2026	Disclosure amount unavailable3.5k shares	--	--
Monopar Therapeutics Inc.MNPR	$2.9M52.7k shares	Grant / ExerciseMar 31, 2026	$86.1K1.6k shares	$54.79	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Monopar Therapeutics Inc.MNPR	--48.3k shares	Grant / ExerciseDec 31, 2025	Disclosure amount unavailable4.3k shares	--	--
Monopar Therapeutics Inc.MNPR	$3.3M50.7k shares	Grant / ExerciseDec 31, 2025	$123.4K1.9k shares	$65.30	--
Monopar Therapeutics Inc.MNPR	$681k9k shares	Grant / ExerciseDec 2, 2025	$681.1K9k shares	$75.94	--
Monopar Therapeutics Inc.MNPR	--52.6k shares	Grant / ExerciseDec 2, 2025	Disclosure amount unavailable13.9k shares	--	--
Monopar Therapeutics Inc.MNPR	--38.7k shares	Grant / ExerciseSep 30, 2025	Disclosure amount unavailable4.3k shares	--	--
Monopar Therapeutics Inc.MNPR	$3.9M48.3k shares	Grant / ExerciseSep 30, 2025	$154.8K1.9k shares	$81.67	--
Monopar Therapeutics Inc.MNPR	--43k shares	Grant / ExerciseJun 30, 2025	Disclosure amount unavailable6.9k shares	--	--
Monopar Therapeutics Inc.MNPR	$1.6M45.9k shares	Grant / ExerciseJun 30, 2025	$107.0K3k shares	$35.78	--
Monopar Therapeutics Inc.MNPR	--42.7k shares	Grant / ExerciseMar 31, 2025	Disclosure amount unavailable1.8k shares	--	--
Monopar Therapeutics Inc.MNPR	$1.5M42k shares	Grant / ExerciseMar 31, 2025	$27.1K744 shares	$36.41	--
Monopar Therapeutics Inc.MNPR	$1.4M43.4k shares	Grant / ExerciseMar 4, 2025	$1.4M43.4k shares	$31.70	--
Monopar Therapeutics Inc.MNPR	--51.7k shares	Grant / ExerciseMar 4, 2025	Disclosure amount unavailable40.6k shares	--	--
Monopar Therapeutics Inc.MNPR	--11.1k shares	Grant / ExerciseDec 31, 2024	Disclosure amount unavailable1.8k shares	--	--
Monopar Therapeutics Inc.MNPR	$901k40.9k shares	Grant / ExerciseDec 31, 2024	$15.9K721 shares	$22.00	--
Monopar Therapeutics Inc.MNPR	$269k39.9k shares	Grant / ExerciseSep 30, 2024	$3.6K535 shares	$6.74	--
Monopar Therapeutics Inc.MNPR	--12.9k shares	Grant / ExerciseSep 30, 2024	Disclosure amount unavailable1.8k shares	--	--
Monopar Therapeutics Inc.MNPR	$141k193.1k shares	Grant / ExerciseJun 30, 2024	$1.5K2k shares	$0.731	--
Monopar Therapeutics Inc.MNPR	--73.3k shares	Grant / ExerciseJun 30, 2024	Disclosure amount unavailable9k shares	--	--
Monopar Therapeutics Inc.MNPR	$138k186.1k shares	BuyJun 20, 2024	$15.3K20.5k shares	$0.7438	--
Monopar Therapeutics Inc.MNPR	$142k165.6k shares	BuyJun 18, 2024	$10.3K12k shares	$0.86	--
Monopar Therapeutics Inc.MNPR	$138k153.6k shares	BuyJun 17, 2024	$10.8K12k shares	$0.8999	--
Monopar Therapeutics Inc.MNPR	$132k141.6k shares	BuyJun 14, 2024	$11.2K12k shares	$0.9313	--
Monopar Therapeutics Inc.MNPR	$118k129.6k shares	BuyJun 13, 2024	$10.9K12k shares	$0.91	--